|
FDMT
|
4D Molecular Therapeutics, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
CVAC
|
CureVac N.V.
|
0.06%
|
US
|
NASDAQ
|
|
CDNA
|
CareDx, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
BLUE
|
bluebird bio, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
BCYC
|
Bicycle Therapeutics plc
|
0.06%
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
ANAB
|
AnaptysBio, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
ADMA
|
ADMA Biologics Inc
|
0.06%
|
US
|
NASDAQ
|
|
ALT
|
Altimmune, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
PTGX
|
Protagonist Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
MCRB
|
Seres Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
KNSA
|
Kiniksa Pharmaceuticals, Ltd.
|
0.05%
|
US
|
NASDAQ
|
|
ITOS
|
iTeos Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
FLGT
|
Fulgent Genetics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
EXAI
|
Exscientia Limited
|
0.05%
|
US
|
NASDAQ
|
|
EQRX
|
EQRx, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
CSTL
|
Castle Biosciences, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|